TY - JOUR A1 - Maier, Hannes A1 - Lenarz, Thomas A1 - Agha-Mir-Salim, Parwis A1 - Agterberg, Martijn J. H. A1 - Anagiotos, Andreas A1 - Arndt, Susan A1 - Ball, Geoffrey R. A1 - Bance, Manohar A1 - Barbara, Maurizio A1 - Baumann, Uwe A1 - Baumgartner, Wolfgang A1 - Bernardeschi, Daniele A1 - Beutner, Dirk A1 - Bosman, Arjan A1 - Briggs, Robert A1 - Busch, Susan A1 - Caversaccio, Marco A1 - Dahm, Markus A1 - Dalhoff, Ernst A1 - Devèze, Arnaud A1 - Ebrahimi-Madiseh, Azadeh A1 - Fraysse, Bernard A1 - Frenzel, Henning A1 - Gavilán, Javier A1 - Ghoncheh, Mohammad A1 - Håkansson, Bo E. V. A1 - Hodgetts, William A1 - Hol, Myrthe Karianne Sophie A1 - Holland, Julian A1 - Holmberg, Marcus A1 - Huber, Alexander A1 - Jenkins, Herman A1 - Katiri, Roulla A1 - Kheirkhah, Kiana A1 - Koitschev, Assen A1 - Kompis, Martin A1 - Lanting, Cris A1 - Lassaletta, Luis A1 - Lerut, Bob A1 - Leuwer, Rudolf A1 - Linder, Thomas A1 - Löwenheim, Hubert Martin A1 - Lustig, Lawrence A1 - Mandavia, Rishi A1 - Manrique, Manuel A1 - Jorge Humberto, Martins A1 - Mertens, Griet A1 - Mlynski, Robert Arndt A1 - Mojallal, Hamidreza A1 - Monini, Simonetta A1 - Monksfield, Peter A1 - Müller, Alexander A1 - Mylanus, Emmanuel A1 - Nakajima, Hideko Heidi A1 - Neudert, Marcus A1 - Offeciers, Erwin A1 - Pfiffner, Flurin A1 - Pietsch, Markus A1 - Plontke, Stefan K.-R. A1 - Prenzler, Nils Kristian A1 - Profant, Milan A1 - Rahne, Torsten A1 - Rajan, Gunesh A1 - Ratuszniak, Anna A1 - Raufer, Stefan A1 - Ray, Jaydip A1 - Reinfeldt, Sabine A1 - Röösli, Christof A1 - Rosenbom, Tove A1 - Salcher, Rolf Benedikt A1 - Schönermark, Matthias A1 - Schwab, Burkard A1 - Skarżyński, Henryk A1 - Skarżyński, Piotr H. A1 - Snapp, Hillary A1 - Sprinzl, Georg A1 - Spearman, Michael A1 - Stenfelt, Stefan A1 - Stieger, Christof A1 - Tringali, Stephane A1 - Truy, Eric A1 - Tysome, James A1 - Van de Heyning, Paul A1 - Verhaert, Nicolas A1 - Wesarg, Thomas A1 - Westerkull, Patrik A1 - Wollenberg, Barbara A1 - Zahnert, Thomas A1 - Zarowski, Andrzej A1 - Snik, Ad T1 - Consensus statement on bone conduction devices and active middle ear implants in conductive and mixed hearing loss T2 - Otology & neurotology N2 - Nowadays, several options are available to treat patients with conductive or mixed hearing loss. Whenever surgical intervention is not possible or contra-indicated, and amplification by a conventional hearing device (e.g., behind-the-ear device) is not feasible, then implantable hearing devices are an indispensable next option. Implantable bone-conduction devices and middle-ear implants have advantages but also limitations concerning complexity/invasiveness of the surgery, medical complications, and effectiveness. To counsel the patient, the clinician should have a good overview of the options with regard to safety and reliability as well as unequivocal technical performance data. The present consensus document is the outcome of an extensive iterative process including ENT specialists, audiologists, health-policy scientists, and representatives/technicians of the main companies in this field. This document should provide a first framework for procedures and technical characterization to enhance effective communication between these stakeholders, improving health care. KW - Active middle ear implants KW - Auditory system KW - Bone conduction devices KW - Consensus statement KW - Health policy KW - Mixed hearing loss KW - Multi-stakeholder approach KW - Rehabilitation KW - Surgery KW - Technical data Y1 - 2022 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/63202 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-632020 SN - 1537-4505 N1 - The first meeting on November 4, 2017 for this consensus project was supported by Cochlear Ltd, MED-EL Medical Electronics and Oticon Medical. VL - 43 IS - 5 SP - 513 EP - 529 PB - Lippincott Williams & Wilkins CY - Philadelphia, Pa. ER -